Latest Breaking News On - Aarti drugs q1 profit - Page 1 : comparemela.com

Further, the board has approved a buyback not exceeding 6,65,000 lakh equity shares for an amount not exceeding Rs 59.85 crore. The buyback price is fixed at Rs 900 per equity share, which is a 76% premium from the last closing price.

Adhish patilAarti drugsEconomic timesAarti drugs q1 resultsAarti drugs share buybackAarti drugs q1 profitAarti drugs target price